BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee S, Kang TW, Song KD, Lee MW, Rhim H, Lim HK, Kim SY, Sinn DH, Kim JM, Kim K, Ha SY. Effect of Microvascular Invasion Risk on Early Recurrence of Hepatocellular Carcinoma After Surgery and Radiofrequency Ablation. Ann Surg. 2019;Online ahead of print. [PMID: 31058694 DOI: 10.1097/sla.0000000000003268] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Wei M, Lin M, Zhong X, Dai Z, Shen S, Li S, Peng Z, Kuang M. Role of Preoperational Imaging Traits for Guiding Treatment in Single ≤ 5 cm Hepatocellular Carcinoma. Ann Surg Oncol. [DOI: 10.1245/s10434-022-11344-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhang Y, Shu Z, Ye Q, Chen J, Zhong J, Jiang H, Wu C, Yu T, Pang P, Ma T, Lin C. Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Multi-Parametric MRI Radiomics. Front Oncol 2021;11:633596. [PMID: 33747956 DOI: 10.3389/fonc.2021.633596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yamamoto M, Kobayashi T, Honmyo N, Oshita A, Abe T, Kohashi T, Onoe T, Fukuda S, Omori I, Imaoka Y, Ohdan H. Liver resection is associated with good outcomes for hepatocellular carcinoma patients beyond the Barcelona Clinic Liver Cancer criteria: A multicenter study with the Hiroshima Surgical study group of Clinical Oncology. Surgery 2021:S0039-6060(21)00891-6. [PMID: 34756748 DOI: 10.1016/j.surg.2021.09.009] [Reference Citation Analysis]
4 Wang Q, Ma L, Li J, Yuan C, Sun J, Li K, Qin L, Zang C, Zhao Y, Zhao Y, Zhang Y. A Novel Scoring System for Patients with Recurrence of Hepatocellular Carcinoma After Undergoing Minimal Invasive Therapies. Cancer Manag Res 2019;11:10641-9. [PMID: 31908536 DOI: 10.2147/CMAR.S224711] [Reference Citation Analysis]
5 Wang H, Lu Y, Liu R, Wang L, Liu Q, Han S. A Non-Invasive Nomogram for Preoperative Prediction of Microvascular Invasion Risk in Hepatocellular Carcinoma. Front Oncol 2021;11:745085. [PMID: 35004273 DOI: 10.3389/fonc.2021.745085] [Reference Citation Analysis]
6 Zhang J, Huang S, Xu Y, Wu J. Diagnostic Accuracy of Artificial Intelligence Based on Imaging Data for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Front Oncol 2022;12:763842. [PMID: 35280776 DOI: 10.3389/fonc.2022.763842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mao S, Yu X, Shan Y, Fan R, Wu S, Lu C. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:1355-65. [PMID: 34805014 DOI: 10.2147/JHC.S339707] [Reference Citation Analysis]
8 He M, Zhang P, Ma X, He B, Fang C, Jia F. Radiomic Feature-Based Predictive Model for Microvascular Invasion in Patients With Hepatocellular Carcinoma. Front Oncol. 2020;10:574228. [PMID: 33251138 DOI: 10.3389/fonc.2020.574228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Sun BY, Gu PY, Guan RY, Zhou C, Lu JW, Yang ZF, Pan C, Zhou PY, Zhu YP, Li JR, Wang ZT, Gao SS, Gan W, Yi Y, Luo Y, Qiu SJ. Deep-learning-based analysis of preoperative MRI predicts microvascular invasion and outcome in hepatocellular carcinoma. World J Surg Oncol 2022;20:189. [PMID: 35676669 DOI: 10.1186/s12957-022-02645-8] [Reference Citation Analysis]
10 Wang L, Ma X, Feng B, Wang S, Liang M, Li D, Wang S, Zhao X. Multi-Sequence MR-Based Radiomics Signature for Predicting Early Recurrence in Solitary Hepatocellular Carcinoma ≤5 cm. Front Oncol 2022;12:899404. [PMID: 35756618 DOI: 10.3389/fonc.2022.899404] [Reference Citation Analysis]
11 Kong J, Yao C, Dong S, Wu S, Xu Y, Li K, Ji L, Shen Q, Zhang Q, Zhan R, Cui H, Zhou C, Niu H, Li G, Sun W, Zheng L. ICAM-1 Activates Platelets and Promotes Endothelial Permeability through VE-Cadherin after Insufficient Radiofrequency Ablation. Adv Sci (Weinh) 2021;8:2002228. [PMID: 33643788 DOI: 10.1002/advs.202002228] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
12 Zheng Z, Guan R, Jianxi W, Zhao Z, Peng T, Liu C, Lin Y, Jian Z, Wu YS. Microvascular Invasion in Hepatocellular Carcinoma: A Review of Its Definition, Clinical Significance, and Comprehensive Management. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/9567041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yang Y, Lin K, Liu L, Qian Y, Yang Y, Yuan S, Zhu P, Huang J, Liu F, Gu F, Fu S, Jiang B, Liu H, Pan Z, Lau WY, Zhou W. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis. Cancer Med 2021;10:2100-11. [PMID: 33650288 DOI: 10.1002/cam4.3814] [Reference Citation Analysis]
14 Li X, Yao Q, Liu C, Wang J, Zhang H, Li S, Cai P. Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know? JHC 2022;Volume 9:379-87. [DOI: 10.2147/jhc.s364742] [Reference Citation Analysis]
15 Yacoub JH, Hsu CC, Fishbein TM, Mauro D, Moon A, He AR, Bashir MR, Burke LMB. Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation-part one: curative intention. Abdom Radiol (NY) 2021;46:3528-39. [PMID: 33835223 DOI: 10.1007/s00261-021-03069-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ding WZ, Liu S, Liu F, Cheng Z, Yu X, Han ZY, Yu J, Liang P. Are all local tumour progressions of HCC related to thermal ablation? A study of the causes and classification of local tumour progression. Eur Radiol 2022. [PMID: 35704110 DOI: 10.1007/s00330-022-08913-1] [Reference Citation Analysis]
17 Hong SB, Choi SH, Kim SY, Shim JH, Lee SS, Byun JH, Park SH, Kim KW, Kim S, Lee NK. MRI Features for Predicting Microvascular Invasion of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Liver Cancer 2021;10:94-106. [PMID: 33981625 DOI: 10.1159/000513704] [Reference Citation Analysis]
18 Wu M, Shi K, Huang R, Liu C, Yin L, Yong W, Sun J, Wang G, Zhong Z, Gao M. Facile preparation of 177Lu-microspheres for hepatocellular carcinoma radioisotope therapy. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.01.007] [Reference Citation Analysis]
19 Zhang XP, Feng JK, Cheng SQ. Reply to: Letter to the Editor "Association of type 2 diabetes mellitus with incidences of microvascular invasion and survival outcomes in hepatitis B virus-related hepatocellular carcinoma after liver resection: A multicenter study". Eur J Surg Oncol 2022:S0748-7983(22)00501-7. [PMID: 35752498 DOI: 10.1016/j.ejso.2022.06.017] [Reference Citation Analysis]
20 Hu C, Song Y, Zhang J, Dai L, Tang C, Li M, Liao W, Zhou Y, Xu Y, Zhang YY, Zhou Y. Preoperative Gadoxetic Acid-Enhanced MRI Based Nomogram Improves Prediction of Early HCC Recurrence After Ablation Therapy. Front Oncol 2021;11:649682. [PMID: 34094938 DOI: 10.3389/fonc.2021.649682] [Reference Citation Analysis]
21 Zhang S, Zhang N, Zhu W, Liu T, Lv J, Jiang W, Zhang Y, Song T, Zhang L, Xie Y, Zhou Y, Lu W. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma. Front Oncol 2022;12:946531. [DOI: 10.3389/fonc.2022.946531] [Reference Citation Analysis]
22 Huang J, Tian W, Zhang L, Huang Q, Lin S, Ding Y, Liang W, Zheng S. Preoperative Prediction Power of Imaging Methods for Microvascular Invasion in Hepatocellular Carcinoma: A Systemic Review and Meta-Analysis. Front Oncol 2020;10:887. [PMID: 32676450 DOI: 10.3389/fonc.2020.00887] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
23 Dong Y, Zuo D, Qiu YJ, Cao JY, Wang HZ, Yu LY, Wang WP. Preoperative prediction of microvascular invasion (MVI) in hepatocellular carcinoma based on kupffer phase radiomic features of sonazoid contrast-enhanced ultrasound (SCEUS): A prospective study. Clin Hemorheol Microcirc 2022. [PMID: 35001883 DOI: 10.3233/CH-211363] [Reference Citation Analysis]
24 Zhao J, Zhang W, Zhang J, Chen YT, Ma WJ, Liu SY, Li FY, Song B. Independent Risk Factors of Early Recurrence After Curative Resection for Perihilar Cholangiocarcinoma: Adjuvant Chemotherapy May Be Beneficial in Early Recurrence Subgroup. Cancer Manag Res 2020;12:13111-23. [PMID: 33376403 DOI: 10.2147/CMAR.S289094] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 An C, Yang H, Yu X, Han Z, Cheng Z, Liu F, Dou J, Li B, Li Y, Li Y, Yu J, Liang P. A Machine Learning Model Based on Health Records for Predicting Recurrence After Microwave Ablation of Hepatocellular Carcinoma. JHC 2022;Volume 9:671-84. [DOI: 10.2147/jhc.s358197] [Reference Citation Analysis]
26 Xin Z, Li J, Zhang H, Zhou Y, Song J, Chen P, Bai L, Chen H, Zhou J, Chen J, Ying B. Cancer Genomic Alterations Can Be Potential Biomarkers Predicting Microvascular Invasion and Early Recurrence of Hepatocellular Carcinoma. Front Oncol 2022;12:783109. [PMID: 35155229 DOI: 10.3389/fonc.2022.783109] [Reference Citation Analysis]
27 Ling Q. Commentary: A preoperative model for predicting microvascular invasion and assisting in prognostic stratification in liver transplantation for HCC regarding empirical criteria. Transl Oncol 2021;14:101234. [PMID: 34626954 DOI: 10.1016/j.tranon.2021.101234] [Reference Citation Analysis]
28 Wang X, Wang W, Ma X, Lu X, Li S, Zeng M, Xu K, Yang C. Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance? Eur Radiol 2020;30:5337-47. [PMID: 32385649 DOI: 10.1007/s00330-020-06861-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Tian Y, Hua H, Peng Q, Zhang Z, Wang X, Han J, Ma W, Chen J. Preoperative Evaluation of Gd-EOB-DTPA-Enhanced MRI Radiomics-Based Nomogram in Small Solitary Hepatocellular Carcinoma (≤3 cm) With Microvascular Invasion: A Two-Center Study. J Magn Reson Imaging 2022. [PMID: 35298849 DOI: 10.1002/jmri.28157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Guo X, Zhang W, Du J, Tao R, Dong W, Huang J, Zhang J, Pan Z, Zhou W, Zhu X, Liu H, Liu F. Acute-Phase Serum Amyloid A May Predict Microvascular Invasion and Early Tumor Recurrence in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma Undergoing Liver Resection. J Invest Surg 2022;:1-9. [PMID: 35143736 DOI: 10.1080/08941939.2022.2035858] [Reference Citation Analysis]
31 Kim TH, Lee JM, Lee DH, Joo I, Park SJ, Yoon JH. Can "no-touch" radiofrequency ablation for hepatocellular carcinoma improve local tumor control? Systematic review and meta-analysis. Eur Radiol 2022. [PMID: 35907024 DOI: 10.1007/s00330-022-08991-1] [Reference Citation Analysis]
32 Hu H, Qi S, Zeng S, Zhang P, He L, Wen S, Zeng N, Yang J, Zhang W, Zhu W, Xiang N, Fang C. Importance of Microvascular Invasion Risk and Tumor Size on Recurrence and Survival of Hepatocellular Carcinoma After Anatomical Resection and Non-anatomical Resection. Front Oncol 2021;11:621622. [PMID: 33816254 DOI: 10.3389/fonc.2021.621622] [Reference Citation Analysis]
33 Xu X, Sun S, Liu Q, Liu X, Wu F, Shen C. Preoperative application of systemic inflammatory biomarkers combined with MR imaging features in predicting microvascular invasion of hepatocellular carcinoma. Abdom Radiol (NY) 2022;47:1806-16. [PMID: 35267069 DOI: 10.1007/s00261-022-03473-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Liu W, Song K, Zheng W, Huo L, Zhang S, Xu X, Wang P, Jia N. Hepatobiliary Phase Features of Preoperative Gadobenate-Enhanced MR can Predict Early Recurrence of Hepatocellular Carcinoma in Patients Who Underwent Anatomical Hepatectomy. Front Oncol 2022;12:862967. [DOI: 10.3389/fonc.2022.862967] [Reference Citation Analysis]
35 Dong S, Li Z, Kong J, Wu S, Gao J, Sun W. Arsenic trioxide inhibits angiogenesis of hepatocellular carcinoma after insufficient radiofrequency ablation via blocking paracrine angiopoietin-1 and angiopoietin-2. Int J Hyperthermia 2022;39:888-96. [PMID: 35848416 DOI: 10.1080/02656736.2022.2093995] [Reference Citation Analysis]
36 Zhong X, Peng J, Xie Y, Shi Y, Long H, Su L, Duan Y, Xie X, Lin M. A nomogram based on multi-modal ultrasound for prediction of microvascular invasion and recurrence of hepatocellular carcinoma. Eur J Radiol 2022;151:110281. [PMID: 35395542 DOI: 10.1016/j.ejrad.2022.110281] [Reference Citation Analysis]
37 Guo Y, Ren Y, Dong X, Kan X, Zheng C. An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation. JHC 2022;Volume 9:343-55. [DOI: 10.2147/jhc.s358539] [Reference Citation Analysis]
38 Meng XP, Tang TY, Ding ZM, Wang J, Lu CQ, Yu Q, Xia C, Zhang T, Long X, Xiao W, Wang YC, Ju S. Preoperative Microvascular Invasion Prediction to Assist in Surgical Plan for Single Hepatocellular Carcinoma: Better Together with Radiomics. Ann Surg Oncol 2022. [PMID: 35102453 DOI: 10.1245/s10434-022-11346-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Song D, Wang Y, Wang W, Cai J, Zhu K, Lv M, Gao Q, Zhou J, Fan J, Rao S, Wang M, Wang X. Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters. J Cancer Res Clin Oncol. 2021 epub ahead of print. [PMID: 33839938 DOI: 10.1007/s00432-021-03617-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Wang X, Yang Z, Meng Z, Sun S. Transforming Commercial Copper Sulfide into Injectable Hydrogels for Local Photothermal Therapy. Gels 2022;8:319. [DOI: 10.3390/gels8050319] [Reference Citation Analysis]
41 Fu J, Ding Z, Chen Q, Lin K, Liu H, Gao Y, Zeng Y, Li H, Shen F, Liu J. Distinct Impacts of Pre-Operative Antiviral Treatment on Post-Operative Outcomes of HBV-related Hepatocellular Carcinoma: A Landmark Analysis. J Cancer 2021;12:170-80. [PMID: 33391413 DOI: 10.7150/jca.47125] [Reference Citation Analysis]
42 Deng Q, He M, Fu C, Feng K, Ma K, Zhang L. Radiofrequency ablation in the treatment of hepatocellular carcinoma. Int J Hyperthermia 2022;39:1052-63. [PMID: 35944905 DOI: 10.1080/02656736.2022.2059581] [Reference Citation Analysis]
43 Feng W, Cao W, Cui C, Pi X, Mi Y. Efficacy of Lipid Nanoparticle-Loaded Sorafenib Combined with Hepatic Artery Chemoembolization in the Treatment of Primary Hepatocellular Carcinoma Complicated with Microvascular Invasion. Disease Markers 2022;2022:1-9. [DOI: 10.1155/2022/4996471] [Reference Citation Analysis]
44 Tang Y, Xu L, Ren Y, Li Y, Yuan F, Cao M, Zhang Y, Deng M, Yao Z. Identification and Validation of a Prognostic Model Based on Three MVI-Related Genes in Hepatocellular Carcinoma. Int J Biol Sci 2022;18:261-75. [PMID: 34975331 DOI: 10.7150/ijbs.66536] [Reference Citation Analysis]
45 Liu W, Zhang L, Xin Z, Zhang H, You L, Bai L, Zhou J, Ying B. A Promising Preoperative Prediction Model for Microvascular Invasion in Hepatocellular Carcinoma Based on an Extreme Gradient Boosting Algorithm. Front Oncol 2022;12:852736. [DOI: 10.3389/fonc.2022.852736] [Reference Citation Analysis]
46 Kong J, Yao C, Ding X, Dong S, Wu S, Sun W, Zheng L. ATPase Inhibitory Factor 1 Promotes Hepatocellular Carcinoma Progression After Insufficient Radiofrequency Ablation, and Attenuates Cell Sensitivity to Sorafenib Therapy. Front Oncol 2020;10:1080. [PMID: 32670888 DOI: 10.3389/fonc.2020.01080] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
47 Cai Y, Fu Y, Liu C, Wang X, You P, Li X, Song Y, Mu X, Fang T, Yang Y, Gu Y, Zhang H, He Z. Stathmin 1 is a biomarker for diagnosis of microvascular invasion to predict prognosis of early hepatocellular carcinoma. Cell Death Dis 2022;13:176. [PMID: 35210426 DOI: 10.1038/s41419-022-04625-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Jeong WK. [Radiologic Diagnosis of Hepatocellular Carcinoma]. Korean J Gastroenterol 2021;78:261-7. [PMID: 34824184 DOI: 10.4166/kjg.2021.138] [Reference Citation Analysis]
49 Fu J, Lei X. Identification of the Immune Subtype of Hepatocellular Carcinoma for the Prediction of Disease-Free Survival Time and Prevention of Recurrence by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data. Front Immunol 2022;13:868325. [DOI: 10.3389/fimmu.2022.868325] [Reference Citation Analysis]
50 Zhang W, Yang R, Liang F, Liu G, Chen A, Wu H, Lai S, Ding W, Wei X, Zhen X, Jiang X. Prediction of Microvascular Invasion in Hepatocellular Carcinoma With a Multi-Disciplinary Team-Like Radiomics Fusion Model on Dynamic Contrast-Enhanced Computed Tomography. Front Oncol 2021;11:660629. [PMID: 33796471 DOI: 10.3389/fonc.2021.660629] [Reference Citation Analysis]
51 . ABDOMEN/BECKEN – No-Touch-Radiofrequenzablation überzeugt bei kleinen hepatozellulären Karzinomen. Rofo 2022;194:598-601. [DOI: 10.1055/a-1692-1374] [Reference Citation Analysis]
52 Zhang K, Tao C, Wu F, Siqin T, Wu J, Rong W. Establishment and Evaluation of a Predictive Model for Early Postoperative Recurrence of Hepatocellular Carcinoma in Patients with Microvascular Invasion. Int J Gen Med 2021;14:2259-74. [PMID: 34113155 DOI: 10.2147/IJGM.S303896] [Reference Citation Analysis]
53 Dong S, Wang W, Chen X, Yang Y, Zhu S, Zeng M, Rao S. Microvascular invasion of small hepatocellular carcinoma can be preoperatively predicted by the 3D quantification of MRI. Eur Radiol. [DOI: 10.1007/s00330-021-08495-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
54 Zhang Q, Lou Y, Bai XL, Liang TB. Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies. World J Gastroenterol 2020; 26(26): 3720-3736 [PMID: 32774053 DOI: 10.3748/wjg.v26.i26.3720] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
55 Fu S, Lai H, Huang M, Li Q, Liu Y, Zhang J, Huang J, Chen X, Duan C, Li X, Wang T, He X, Yan J, Lu L. Multi-task deep learning network to predict future macrovascular invasion in hepatocellular carcinoma. EClinicalMedicine 2021;42:101201. [PMID: 34917908 DOI: 10.1016/j.eclinm.2021.101201] [Reference Citation Analysis]
56 Wang F, Chen Q, Zhang Y, Chen Y, Zhu Y, Zhou W, Liang X, Yang Y, Hu H. CT-Based Radiomics for the Recurrence Prediction of Hepatocellular Carcinoma After Surgical Resection. JHC 2022;Volume 9:453-65. [DOI: 10.2147/jhc.s362772] [Reference Citation Analysis]
57 Luo D, Zhao D, Zhang M, Hu C, Li H, Zhang S, Chen X, Huttad L, Li B, Jin C, Lin C, Han B. Alternative Splicing-Based Differences Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Genes, Immune Microenvironment, and Survival Prognosis. Front Oncol 2021;11:731993. [PMID: 34760694 DOI: 10.3389/fonc.2021.731993] [Reference Citation Analysis]
58 Zhang K, Tao C, Siqin T, Wu J, Rong W. Establishment, validation and evaluation of predictive model for early relapse after R0 resection in hepatocellular carcinoma patients with microvascular invasion. J Transl Med 2021;19:293. [PMID: 34229698 DOI: 10.1186/s12967-021-02940-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Chen Z, Wang T, Chen C, Hong X, Yu J, Ma Y, Guo Y, Huang C, He X, Ju W, Chen M. Circulating Tumor Cell Is a Clinical Indicator of Pretransplant Radiofrequency Ablation for Patients with Hepatocellular Carcinoma. J Oncol 2021;2021:7776389. [PMID: 34712326 DOI: 10.1155/2021/7776389] [Reference Citation Analysis]
60 Qiu Y, Yang Y, Wang T, Shen S, Wang W. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients With Microscopic Portal Vein Invasion. Front Oncol 2022;12:831614. [DOI: 10.3389/fonc.2022.831614] [Reference Citation Analysis]
61 Wang L, Wu M, Li R, Xu X, Zhu C, Feng X. MVI-Mind: A Novel Deep-Learning Strategy Using Computed Tomography (CT)-Based Radiomics for End-to-End High Efficiency Prediction of Microvascular Invasion in Hepatocellular Carcinoma. Cancers (Basel) 2022;14:2956. [PMID: 35740620 DOI: 10.3390/cancers14122956] [Reference Citation Analysis]
62 Xie C, Wu H, Pan T, Zheng X, Yang X, Zhang G, Lian Y, Lin J, Peng L. A novel panel based on immune infiltration and tumor mutational burden for prognostic prediction in hepatocellular carcinoma. Aging (Albany NY) 2021;13:8563-87. [PMID: 33714200 DOI: 10.18632/aging.202670] [Reference Citation Analysis]